Company Overview and News

Tesla Model 3 And Chevy Bolt Strain LIB Market

2018-01-17 seekingalpha
Tesla (TSLA) reported Q4 production and delivery numbers on January 3rd that were in line with my expectations. Tesla delivered 29,870 vehicles of which 15,200 were Model S, 13,120 were Model X, and 1,550 were Model 3. Model S and X deliveries continue to grow with a 27% increase over Q4 2016 and a 9% increase over Q3 2017.
Upvote Downvote

Cougar Metals NL sets for lithium reveal

Cougar Metals NL (ASX:CGM) has exploration results on the table from its Ceara Lithium Project, and the ASX has granted the company a trading halt to prepare.
Upvote Downvote

Cougar Metals to deliver graphite details from Madagascar

Cougar Metals NL (ASX:CGM) is preparing to reveal details in relation its option agreement with DNI Metals Inc over the Toamasina Graphite Project in Madagascar.
Upvote Downvote

Cougar Metals’ shares rise on sampling high grade lithium in Brazil

Cougar Metals NL (ASX:CGM) has received positive results from the first-pass soil and rock chip sampling at the Solonopole Lithium Project in Brazil. The company’s shares were trading circa 12% higher intra-day, at $0.019.
Upvote Downvote

Cougar Metals has lithium results on the table

Cougar Metals NL (ASX:CGM) has some very interesting news flow coming, with the company entering a trading halt this morning pending results from the Ceara Lithium Project.
Upvote Downvote

Cougar Metals takes advantage of galloping share price to raise funds

Cougar Metals NL's (ASX:CGM) shares closed yesterday at $0.018, and the company has entered a trading halt this morning pending details of a capital raising. A month ago, shares could have been snapped up for just $0.006. Cougar has exposure to lithium and graphite. The halt will remain in place until the opening of trade on Friday 15th September 2017, or earlier if an announcement is made to the market.
Upvote Downvote

Graphite Update: Syrah, Magnis, Kibaran, Mason And Others

2017-07-24 seekingalpha
The shift to electric vehicles will require the opening of several new graphite mines as the demand for graphite exceeds supply in the next 20 years.
Upvote Downvote

Tax Convention Signed Between Canada and Madagascar - DNI to Form Mauritian Company - DNI Saprolite Graphite Advantage

2017-04-03 accesswire
TORONTO, ON / ACCESSWIRE / April 3, 2017 / DNI Metals Inc. (DNI: CSE) (FSE: DG7N) (OTC PINK: DMNKF) ("DNI" or the "Company")
Upvote Downvote

DNI Metals Completes DA with Cougar Metals - Drilling to Start - Saprolite Graphite Advantage

2017-03-27 accesswire
TORONTO, ON / ACCESSWIRE / March 27, 2017 / DNI Metals Inc. (CSE: DNI) (FSE: DG7N) (OTC PINK: DMNKF) ("DNI" or the "Company").
Upvote Downvote

Cougar Metals NL to lift cash balance

Cougar Metals NL (ASX:CGM) has been granted a trading halt by the ASX, pending capital raising details.
Upvote Downvote

DNI Metals Receives Purchase Order for 2,320 Tonnes of Graphite

2017-03-13 accesswire
TORONTO, ON / ACCESSWIRE / March 13, 2017 / DNI Metals Inc. (CSE: DNI) (FSE: DG7N) (OTC PINK: DMNKF) ("DNI" or the "Company"). DNI will deliver 2,320 metric tonnes of graphite to a customer's facility in the United States. Monthly Shipments will commence in July and completed by December 2017.
Upvote Downvote

Cougar Metals NL identifies high-priority lithium targets in Brazil

Cougar Metals NL (ASX:CGM) has identified four high-priority targets from a lithium pegmatite targeting study at its Solonopole Project in northern Brazil.
Upvote Downvote

DNI's Visits Largest Graphite Mine in the World Located in Brazil to Set its Shipment Schedule for 2017 - Brazil and Madagascar - Saprolite Advantage

2017-03-01 accesswire
TORONTO, ON / ACCESSWIRE / March 1, 2017 / DNI Metals Inc. (CSE: DNI) (FSE: DG7N) (OTC Pink: DMNKF) ("DNI" or the "Company")
Upvote Downvote

CLARIFICATION: DNI Metals Inc Signs LOI Valued Up to $4.5 Million

2016-12-16 accesswire
TORONTO, ON / ACCESSWIRE / December 16, 2016 / DNI Metals Inc. (CSE: DNI) (FSE: DG7N) (OTC Pink: DMNKF) ("DNI" or the "Company").
Upvote Downvote

DNI Metals Inc. Signs LOI Valued up to $4.5 Million

2016-12-16 accesswire
TORONTO, ON / ACCESSWIRE / December 16, 2016 / DNI Metals Inc. (CNSX: DNI) (FSE: DG7N) (OTC PINK: DMNKF) ("DNI" or the "Company").
Upvote Downvote

Related Articles

GNCA: Genocea Biosciences Analysis and Research Report

11h - Asif

Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...

AMZN:, Inc Analysis and Research Report

12h - Asif

Overview opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...